| Literature DB >> 26877856 |
Rui Zhao1, Wenli Hao2, Baoling Ma3, Zhibao Chen2.
Abstract
OBJECTIVES: Sub-health has been described as a chronic condition of unexplained deteriorated physiological function, which falls between health and illness. In the present study, we evaluated the effects of Lycium barbarum polysaccharide (LBP), a polysaccharide fraction purified from Lycium barbarum (L. barbarum) on the sub-health mice.Entities:
Keywords: Anti-fatigue; Antioxidant; Immunity; Lycium bararum; Polysaccharide; Sub-health
Year: 2015 PMID: 26877856 PMCID: PMC4744366
Source DB: PubMed Journal: Iran J Basic Med Sci ISSN: 2008-3866 Impact factor: 2.699
Behavior evaluation of sub-health mice model (Mean±S.D.)
| Groups | n | Body weight (g) | Autonomic activity times (x) | Escaping darkness times(x) | Accumulative immobile time within 5 min (second) | Exhaustion time (min) |
|---|---|---|---|---|---|---|
| Normal Control | 10 | 28.47±2.16 | 125±11 | 2.3±0.32 | 19.10±5.18 | 27.31±8.32 |
| Model | 40 | 19.35±2.02 | 93±17 | 1.09±0.21 | 65.62±8.32 | 14.55±5.62 |
Compared with control.
P<0.05.
P<0.01.
Figure 1Effect of Lycium bararum polysaccharide (LBP) on activities of superoxide dismutase (T-SOD), catalase (CAT) and level of malondialdehyde (MDA) in serum of sub-health and control mice. Compared with control, ▲P<0.05 ▲▲P<0.01 Compared with model, ☆P<0.05 ☆☆P<0.01. The dose in LBP (L) treated group is 50 mg•kg-1, and the dose in LBP (H) treated group is 100 mg.kg-1
Effect of Lycium bararum polysaccharide (LBP) on immunity in sub-health mice (±SD, n=10)
| Groups | Thymus index (mg·10g-1) | Spleen index (mg·10g-1) | Proliferation OD difference |
|---|---|---|---|
| Control | 18.12±2.31 | 60.45±9.67 | 0.363±0.048 |
| Model | 12.97±1.85[ | 49.34±8.71[ | 0.182±0.052[ |
| LBP (50 mg·kg-1) | 12.32±1.35[ | 50.89±6.62[ | 0.193±0.035[ |
| LBP (100 mg·kg-1) | 17.04±3.27 | 58.78±9.25 | 0.357±0.048 |
Compared with control, ▲P<0.05.
P<0.01.
Compared with model.
P<0.05.
Figure 2Effect of Lycium bararum polysaccharide (LBP) on thymus structure of sub-health mice (amplificatory rate, 40×10). (A) microstructure of thymus tissue of control group; (B) microstructure of thymus tissue of sub-health group; (C) microstructure of thymus tissue of LBP (L) treated group; (D) microstructure of thymus tissue of LBP (H) treated group. The dose in LBP (L) treated group is 50 mg•kg-1, and the dose in LBP (H) treated group is 100 mg•kg-1
Figure 3Effect of Lycium bararum polysaccharide (LBP) on apoptosis number of thymus cells in sub-health mice (amplificatory rate, 10×10). (A) TUNEL staining of thymus tissue of control group; (B) TUNEL staining of thymus tissue of sub-health group; (C) TUNEL staining of thymus tissue of LBP (L) treated group; (D)TUNEL staining of thymus tissue of LBP (H) treated group. The dose in LBP (L) treated group is 50 mg•kg-1, and the dose in LBP (H) treated group is 100 mg•kg-1
Effect of Lycium bararum polysaccharide (LBP) on swimming time of weight loading and serum urea nitrogen and liver glycogen in sub-health and control mice (Mean±SD, n=10)
| Groups | Swimming time of weight loading (min) | Serum urea nitrogen (mmol·L-1) | Hepatic glycogen (mg·g-1) |
|---|---|---|---|
| Control | 18.37±2.36 | 6.04±1.38 | 6.94±1.35 |
| Model | 9.25±1.31[ | 11.46±3.25[ | 4.95±1.16[ |
| LBP (50 mg·kg-1) | 9.42±1.26 | 10.96±2.31 | 5.23±1.21 |
| LBP (100 mg·kg-1) | 17.79±2.41 | 7.18±1.44 | 6.75±1.52 |
Compared with control.
P<0.05.
P<0.01.
Compared with model.
P<0.05.
P<0.01.